-
Mashup Score: 5Daniel Coyne on Twitter - 1 month(s) ago
Read the full article here
Source: endpts.comCategories: Expert PicksTweet
-
Mashup Score: 2CheckMate 8HW: Nivolumab Plus Ipilimumab Offers Better PFS for mCRC Over Chemotherapy Alone | Docwire News - 3 month(s) ago
At ASCO GI 2024, Dr. Thierry Andre presented the first results of the CheckMate 8HW study on the use of nivolumab plus ipilimumab versus chemotherapy and nivolumab monotherapy.
Source: www.docwirenews.comCategories: Expert PicksTweet
-
Mashup Score: 2
Dr. Christopher Lieu gives an overview of some of the top presentations and data to look out for at ASCO GI 2024, and discusses the importance of the event.
Source: www.docwirenews.comCategories: Expert PicksTweet
-
Mashup Score: 0
Read the full article here
Source: guoncologynow.comCategories: Expert PicksTweet
-
Mashup Score: 2
Dr. Christopher Lieu gives an overview of some of the top presentations and data to look out for at ASCO GI 2024, and discusses the importance of the event.
Source: www.docwirenews.comCategories: Expert PicksTweet
-
Mashup Score: 0
Read the full article here
Source: guoncologynow.comCategories: Expert PicksTweet
-
Mashup Score: 0Uro Today Highlights - 6 month(s) ago
Read the full article here
Source: www.urotoday.comCategories: Expert PicksTweet
-
Mashup Score: 0Landiolol and Organ Failure in Patients With Septic Shock - 6 month(s) ago
Read the full article here
Source: jamanetwork.comCategories: Expert PicksTweet
-
Mashup Score: 0
Standardizing the definition of intermediate-risk (IR) non-muscle-invasive bladder cancer (NMIBC), which is a heterogeneous disease, is critical for appropriate management of patients. The International Bladder Cancer Group recommends classification of IR NMIBC tumors and personalized management bas …
Source: PubMedCategories: Dental, Latest Headlines, Onc News and JournalsTweet
-
Mashup Score: 0
Standardizing the definition of intermediate-risk (IR) non-muscle-invasive bladder cancer (NMIBC), which is a heterogeneous disease, is critical for appropriate management of patients. The International Bladder Cancer Group recommends classification of IR NMIBC tumors and personalized management bas …
Source: PubMedCategories: Dental, Latest Headlines, Onc News and JournalsTweet
Daprodustat (Jesduvroq) GSK pulls plans to market anemia drug in EU and other markets, citing 'reduced opportunity' - https://t.co/XSRLX6w4wF https://t.co/hWpfLZ1kLm